Scarica l'app Stockscreener
7.5487
3.15%
-0.2413
Precedente Chiudi:
$7.79
Aprire:
$7.28
Volume 24 ore:
2.76M
Relative Volume:
0.39
Capitalizzazione di mercato:
$1.26B
Reddito:
$2.59B
Utile/perdita netta:
$-981.73M
Rapporto P/E:
-1.3083
EPS:
-5.77
Flusso di cassa netto:
$206.95M
1 W Prestazione:
-11.86%
1M Prestazione:
-19.99%
6M Prestazione:
-13.08%
1 anno Prestazione:
-47.64%
Intervallo 1D:
$7.22
$7.63
Intervallo di 1 settimana:
$7.22
$8.5099
Portata 52W:
$6.76
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
2 MANHATTANVILLE ROAD, PURCHASE, NY
Confronta TDOC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.5299 | 1.26B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
221.12 | 36.00B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
55.02 | 10.33B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
46.96 | 8.16B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
83.62 | 7.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.28 | 6.24B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Iniziato | Goldman | Buy |
| 2024-09-17 | Reiterato | Jefferies | Hold |
| 2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-08-02 | Downgrade | Berenberg | Buy → Hold |
| 2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-07-28 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-28 | Downgrade | Needham | Buy → Hold |
| 2022-07-06 | Reiterato | BofA Securities | Neutral |
| 2022-05-05 | Downgrade | Argus | Buy → Hold |
| 2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-03 | Aggiornamento | Argus | Hold → Buy |
| 2022-02-23 | Reiterato | BofA Securities | Neutral |
| 2022-02-23 | Reiterato | Craig Hallum | Hold |
| 2022-02-23 | Reiterato | Evercore ISI | In-line |
| 2022-02-23 | Reiterato | Goldman | Buy |
| 2022-02-23 | Reiterato | JP Morgan | Overweight |
| 2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Reiterato | Needham | Buy |
| 2022-02-23 | Reiterato | Oppenheimer | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-08 | Reiterato | Piper Sandler | Overweight |
| 2021-12-02 | Ripresa | Jefferies | Hold |
| 2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-28 | Reiterato | Barclays | Equal Weight |
| 2021-10-28 | Reiterato | BofA Securities | Neutral |
| 2021-10-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-10-28 | Reiterato | Citigroup | Buy |
| 2021-10-28 | Reiterato | Craig Hallum | Hold |
| 2021-10-28 | Reiterato | Needham | Buy |
| 2021-10-28 | Reiterato | Oppenheimer | Outperform |
| 2021-10-28 | Reiterato | Piper Sandler | Overweight |
| 2021-10-28 | Reiterato | UBS | Neutral |
| 2021-10-19 | Iniziato | Wells Fargo | Overweight |
| 2021-08-02 | Downgrade | Argus | Buy → Hold |
| 2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-22 | Iniziato | Evercore ISI | In-line |
| 2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-07-13 | Iniziato | Argus | Buy |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Iniziato | UBS | Neutral |
| 2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Teladoc (TDOC) Gains But Lags Market: What You Should Know - Yahoo
Teladoc Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your RightsTDOC - ACCESS Newswire
Teladoc Health (NYSE:TDOC) Expands Connected Care Partnerships Amid US Tariff Concerns - Yahoo Finance
Hims & Hers to sell Lilly's Zepbound on its telehealth platform - Yahoo Finance
Virtual Care Market Forecasted for Major Expansion by 2031 | - openPR.com
Chronic Disease Management Market Opportunity Potential: - openPR.com
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? - Yahoo Finance
(TDOC) On The My Stocks Page - Stock Traders Daily
Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report? - Yahoo Finance
Future Business Opportunities in Enterprise Telemedicine - openPR
Telepsychiatry Market 2025: Sustainable Growth, Key Trends, - openPR
Telestroke Services Market to Witness Remarkable Growth with ScienceSoft, SEVARO, Teladoc Health, Inc - openPR
Global Telehealth Services Market Is Booming So Rapidly - openPR
Teladoc (TDOC) Flat As Market Sinks: What You Should Know - Yahoo Finance
Best Statistical Video-Based Mental Health Platforms Market - openPR
Teladoc's Meltdown May Not Be Over YetMinimal Growth Opportunities (NYSE:TDOC) - Seeking Alpha
Teladoc (TDOC): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
U.S. Telehealth Counseling Market Projected To Witness - openPR
North America Telemedicine Market Major Manufacturers, Trends, Demand, Share Analysis to 2028 - openPR
Teladoc Beats Investor Suit For Good On 2nd Circ. Remand - Law360
Teladoc Defeats Securities Class Suit Over Livongo Merger Again - Bloomberg Law
Digital Therapeutics Market Size, Growth Trends & Forecast - openPR
Teladoc Health president sells shares worth $33,965 By Investing.com - Investing.com South Africa
Teladoc Health president sells shares worth $79,775 By Investing.com - Investing.com South Africa
Teladoc Health president sells $69,632 in stock - Investing.com India
Teladoc Health president sells shares worth $79,775 - Investing.com India
Teladoc Health’s chief legal officer sells $92,756 in stock - Investing.com
Teladoc Health Executives Conduct Series of Stock Transactions - TradingView
Teladoc Health Executives Sell Shares - TradingView
Hinge Health is Going Public. Is It Wise? - Dealbreaker
Online Doctor Consultation Market is Estimated to Reach US 114.3 - openPR
Teladoc Health president sells shares worth $33,965 - Investing.com
Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
New Empirical Research Report on Fast-track Telemedicine - openPR
Teladoc Health (TDOC): Among the Best Diabetes Stocks to Buy According to Billionaires - Insider Monkey
Unparalleled Research on Video-Based Telemedicine Platforms - openPR
Spotting Winners: Teladoc (NYSE:TDOC) And Online Marketplace Stocks In Q4 - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
BetterHelp Says Insurer Must Cover FTC Deal, Privacy Litigation - Bloomberg Law
Upcoming Opportunities in Pediatric Telehealth Solutions - openPR
Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy? - Yahoo
Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth - MSN
Virtual Care Market Report | Industry Trends & Future Outlook - openPR
Teladoc Expands Specialty Care Access With Carrum Health Partnership - MSN
Carrum Health Selected by Teladoc Health as Centers of Excellence Partner - Quantisnow
Carrum Health Selected by Teladoc Health as Centers of Excellence Partner – Company Announcement - Financial Times
Virtual Health Service Market Projected To Witness Substantial Growth 2025-2032:Teladoc Health, Amwell, Doctor - EIN News
Teladoc's Game-Changing Partnership Solves Major Healthcare Integration Challenge for 93M Members - Stock Titan
Teladoc Doubles Down on Connected Care With New Partnerships - MSN
Teladoc Doubles Down On Connected Care With New Partnerships - Barchart
Cylinder joins Teladoc Health’s Connected Care Program to expand access to virtual digestive care - TradingView
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.77%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):